Immunoprophylaxis with simulect (Basiliximab) in kidney transplantation: results from routine clinical practice at 18 kidney transplant units

By Rengel M.   Fernandez Rodriguez A.   Gomez Huertas E.   Plaza J.J.   Ruiz San Millan J.C.   Oppenheimer F.   Bustamante J.   Checa D.   Sanchez Plumed J.A.   Garcia Perez J.   Sanz Guajardo A.   Llorente S.   Martin Govantes J.A.   Gentil M.A.   Gomez Ullate P.   Sanchez Guisande D.   Puig J.M.   Fernandez C.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1691-1693

Elsevier

Access to resources Recommend Favorite

Duration of action of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in pediatric kidney transplant recipients

By Sterkers G.   Baudouin V.   Ansart-Pirenne H.   Maisin A.   Niaudet P.   Cochat P.   Loirat C.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2757-2759

Elsevier

Access to resources Recommend Favorite

Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients

By Shah M.H.   Bokhari M.Z.M.   Bokhari M.T.M.   Farooq A.   Yousaf S.M.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2737-2738

Elsevier

Access to resources Recommend Favorite

Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab

By Folkmane I.   Bicans J.   Amerika D.   Chapenko S.   Murovska M.   Rosentals R.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3209-3210

Elsevier

Access to resources Recommend Favorite

Histopathological findings of 10-year protocol biopsy in pediatric kidney transplant recipients

By Kamimaki I.   Shishido S.   Ikeda M.   Honda M.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3130-3131

Elsevier

Access to resources Recommend Favorite